» Articles » PMID: 39186148

Effects of Metal Oxide Nanoparticles on Healthy and Psoriasis-like Human Epidermal Keratinocytes in Vitro

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2024 Aug 26
PMID 39186148
Authors
Affiliations
Soon will be listed here.
Abstract

The use of metal oxide nanoparticles (NPs) in skincare products has significantly increased human skin exposure, raising safety concerns. Whilst NP's ability to penetrate healthy skin is minimal, studies have demonstrated that metal oxide NPs can induce toxicity in keratinocytes through direct contact. Moreover, NP's effect on common skin disorders like psoriasis, where barrier impairments and underlying inflammation could potentially increase NP penetration and worsen nanotoxicity is largely unstudied. In this paper, we investigated whether psoriasis-like human keratinocytes (Pso HKs) would exhibit heightened toxic responses to titanium dioxide (TiO), zinc oxide (ZnO), and/or silica (SiO) NPs compared to healthy HKs. Cells were exposed to each NP at concentrations ranging between 0.5 and 500 µg/ml for 6, 24, and 48 h. Amongst the metal oxide NPs, ZnO NPs produced the most pronounced toxic effects in both cell types, affecting cell viability, inducing oxidative stress, and activating the inflammasome pathway. Notably, only in ZnO NPs-treated Pso HKs, trappin-2/pre-elafin was cleaved intracellularly through a non-canonical process. In addition, tissue remodelling-related cytokines were upregulated in ZnO NP-treated Pso HKs. The full impact of the observed outcomes on psoriatic symptoms will need further evaluation. Nonetheless, our findings indicate the importance of understanding the sub-lethal impacts of NP exposures on keratinocytes, even though direct exposure may be low, particularly in the context of skin disorders where repeated and long-term exposures are anticipated.

References
1.
Alder H, Taccioli C, Chen H, Jiang Y, Smalley K, Fadda P . Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis. 2012; 33(9):1736-44. PMC: 3514898. DOI: 10.1093/carcin/bgs204. View

2.
Anjum S, Ishaque S, Fatima H, Farooq W, Hano C, Abbasi B . Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives. Pharmaceuticals (Basel). 2021; 14(8). PMC: 8401281. DOI: 10.3390/ph14080707. View

3.
Avbelj M, Hafner-Bratkovic I, Lainscek D, Mancek-Keber M, Peternelj T, Panter G . Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1. Front Immunol. 2022; 12:790258. PMC: 8767097. DOI: 10.3389/fimmu.2021.790258. View

4.
Pomella S, Porrazzo A, Cassandri M, Camero S, Codenotti S, Milazzo L . Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma. Int J Mol Sci. 2022; 23(21). PMC: 9656983. DOI: 10.3390/ijms232113281. View

5.
Benhadou F, Mintoff D, Del Marmol V . Psoriasis: Keratinocytes or Immune Cells - Which Is the Trigger?. Dermatology. 2018; 235(2):91-100. DOI: 10.1159/000495291. View